Thursday, 3 August 2017

Tutorial 1st. August 2017


3rd. August 2017.

56
EMQ. APH
57
EMQ. Drugs in O&G 2
58
EMQ. Menopause. NG23. Definition & diagnosis
59
SBA. Flu and pregnancy
60
EMQ. Kallmann’s syndrome

56. Antepartum haemorrhage.
Lead-in.
The following scenarios relate to APH.
Pick one option from the option list.
Abbreviations.
ART:      assisted reproduction technology
FGR:      fetal growth restriction
PET:      pre-eclampsia
Option list.
A.        genital tract bleeding ≥ 500 ml. from 24 weeks until the delivery of the baby
B.         genital tract bleeding ≥ 500 ml. from 24 weeks until the delivery of the placenta.
C.         genital tract bleeding ≥ 500 ml. from 24 weeks, or earlier if the baby is live-born, until the delivery of the baby.
D.        1
E.         2
F.         3
G.        4
H.        5
I.           6
J.          7
K.         8
L.          9
M.      10
N.        15
O.        20
P.         30
Q.        50
R.         100
S.         500
T.         1,000
U.        true
V.        false
W.      none of the above
Scenario 1.
What is the definition of APH?
Scenario 2.
What is the upper limit in ml. for minor APH
Scenario 3.
What is the upper limit in ml. of major haemorrhage
Scenario 4.
What is the % risk of recurrence after 1 abruption?
Scenario 5.
What is the % risk of recurrence after 2 abruptions?
Scenario 6.
What is the major risk factor for placental abruption.
Scenario 7
List 10 risk factors for placental abruption.
Scenario 8
List 6 risk factors for placenta previa.
Scenario 9
In what % of pregnancies does APH occur?
Scenario 10
With regards to steps that can be taken to reduce the incidence of APH, what things would you include in a viva in the OSCE?

57. Drugs in Pregnancy 2.
Lead-in.
The following scenarios relate to some common drugs used in pregnancy.
Abbreviations.
NSAID.  non-steroidal anti-inflammatory drug.
Option list.
I have not given one to make you think! And, in the exam, you should be deciding your answer before you check the option list.
Scenario 1.
What is the generic name for Prostin?
Scenario 2.
What kind of drug is Prostin?
Scenario 3.
What is the generic name for Misoprostol?
Scenario 4.
What kind of drug is Misoprostol?
Scenario 5.
What is the generic name for Gemeprost?
Scenario 6.
What kind of drug is Gemeprost?
Scenario 7
What is the generic name for Mifepristone?
Scenario 8
What king of drug is Mifepristone?
Scenario 9
What are the constituents of a 1 ml. ampoule of Syntometrine?
Scenario 10
What is the generic name for Carbetocin?
Scenario 11
What kind of drug is Carbetocin?
Scenario 12
What is the generic name for Hemabate?
Scenario 13
What kind of drug is Hemabate?
Scenario 14
What is the generic name for Atosiban?
Scenario 15
What kind of drug is atosiban?
Scenario 16
What if the generic name for Cervagem?
Scenario 17
What kind of drug is Cervagem?
Scenarion 18
What is the cost of 1mg. of Prostin E2 gel and what are its storage requirements?
Scenarion 19
What is the cost of a 1mg. Gemeprost pessary and what are its storage requirements?
Scenarion 20
What is the cost of 200 mcg. of misoprostol and what are its storage requirements?

58. Menopause NG23. Diagnosis & definitions.
Abbreviations.
AFC:      antral follicle count.
AMH:    anti-Müllerian hormone.
POF:      premature ovarian failure.
POI:       premature ovarian insufficiency.
Question 1.
Which adjective did NICE use in relation to ideal care in recommendation 1.1.1 of NG23?
Option List
A.       
best
B.       
holistic
C.       
individualised
D.       
personalised
E.        
privatised
Question 2.
What is the average age at the menopause?
Option List
A.       
49 years
B.       
50 years
C.       
51 years
D.       
52 years
E.        
53 years
Question 3.
What age limit is used for the diagnosis of premature ovarian insufficiency?
Option List
A.       
30 years
B.       
35 years
C.       
37 years
D.       
40 years
E.        
45 years
Question 4.
What is the approximate incidence of premature ovarian insufficiency?
Option List
A.       
0.1%
B.       
0.5%
C.       
1%
D.       
2%
E.        
5%
Question 5.
What is the definition of the perimenopause?
Question 6.
What is the definition of the postmenopause?
Question 7.
What is the definition of premature ovarian insufficiency?
Question 8.
A healthy physics teacher of 35 is diagnosed as menopausal. There is no obvious explanation. Which of the following conditions could be the undiagnosed hereditary cause?
Option List
A.       
Cystic fibrosis carrier status
B.       
Elliptocytosis
C.       
Fragile X carrier status
D.       
Galactosaemia
E.        
Polycythaemia vera
Question 9.
A healthy woman of 52 presents with amenorrhoea for 15 months and vasomotor symptoms. She is not taking any drugs. What tests should be done to confirm the diagnosis of the menopause.
Option List.
A.       
FSH
B.       
FSH & LH
C.       
FSH & oestradiol
D.       
AMH
E.        
None of the above
Question 10.
A healthy woman of 46 presents with vasomotor symptoms and irregular periods. She is not taking any drugs. What tests should be done to confirm the diagnosis of the menopause?
Option List.
A.       
FSH
B.       
FSH & LH
C.       
FSH & oestradiol
D.       
AMH
E.        
None of the above
Question 11.
Which tests does NICE say should not be used to diagnose the menopause and perimenopause in women > 45 years?
List of possible investigations.
A.       
AFCA
B.       
MH
C.       
CT scan of pituitary fossa
D.       
inhibin A
E.        
inhibin B
F.        
oestradiol
G.       
ovarian volume
H.       
prolactin
I.         
thyroid function tests
Question 12.
What does NICE recommend with regard to the use of FSH in relation to diagnosis of the menopause?
Question 13.
What does NICE recommend with regard to the use of FSH in relation to diagnosis of the perimenopause?
Question 14.
What does NICE say about the cost of FSH assay?
Question 15.
Which of the following statements, if any, are true in relation to the advice from NICE about the diagnosis of the menopause?
Option List
A
diagnose without lab tests in healthy women > 45 years with menopausal symptoms
B
diagnose without lab tests in healthy women > 50 years with menopausal symptoms
C
diagnose without lab tests in women > 50 years with amenorrhoea > 6/12 and not taking hormones
D
diagnose without lab tests in women > 55 years with amenorrhoea > 6/12 and not taking hormones
E
diagnose on symptoms without lab tests in women > 45 years who have had hysterectomy and are not taking hormones
F
none of the above
Question 16.
Which of the following statements is true in relation to the advice from NICE about the diagnosis of the perimenopause?
Option List
A
diagnose without lab tests in healthy women > 45 years with menopausal symptoms
B
diagnose without lab tests in healthy women > 50 years with menopausal symptoms
C
diagnose without lab tests in women > 50 years with amenorrhoea > 6/12 and not taking hormones
D
diagnose without lab tests in women > 55 years with amenorrhoea > 6/12 and not taking hormones
E
diagnose on symptoms without lab tests in women > 45 years who have had hysterectomy and are not taking hormones
F
none of the above
Question 17.
What does NICE recommend with regard to the use of oestradiol assay in relation to diagnosis of the menopause and perimenopause?
Question 18.
What does NICE recommend in relation to the diagnosis of POI?
Question 19.
NICE uses the term “urogenital atrophy” for the changes that may accompany the menopause. There is now a preferred term – what is it?
Question 20.
NICE describes 3 ‘challenges’, parts of NG23 that could have ‘a big impact on practice’ but be ‘challenging to implement’.
Which, if any, of the following are included in the ‘challenges’.
Possible ‘challenges’
A
increasing the uptake of HRT or non-hormonal alternatives to ↓ the burdens caused by osteoporosis in an ageing population
B
increasing the uptake of HRT to ↓ the burdens caused by Alzheimer’s disease in an ageing population
C
reducing unnecessary use of FSH tests in the diagnosis of the menopause
D
providing better information about the long-term benefits and risks of HRT
E
providing adequate specialist services for an ageing population
F
encouraging GPs to discuss the benefits and risks of HRT with all of their menopausal patients
Option List
1
A + B + C + D + E + F
2
A + B + C + D + E
3
B + D + E + F
4
C + D + E
5
C + D  + F

59. Flu and pregnancy
Question 1.
Lead-in
What did MBRRACE say about flu & pregnancy in its first report in 2014?
Option List
Pick the best option from the following list.
F.        
1 in 11 women died from flu
G.       
1 in 11 women died from flu and flu vaccination could have prevented ½ of the deaths
H.       
1 in 21 women died from flu
I.         
1 in 21 women died from flu and flu vaccination could have prevented ½ of the deaths
J.         
1 in 51 women died from flu
K.        
1 in 51 women died from flu and flu vaccination could have prevented ½ of the deaths
Question 2.
Lead-in
How many types of flu virus are recognised?
Pick the best option from the following list.
Option List
F.        
3
G.       
5
H.       
10
I.         
15
J.         
>100
Question 3.
Lead-in
Why can’t we have a universal flu vaccine?
Pick the statements from the following list that are true.
List of statements.
A.       
The main surface antigens are haemagglutinin and neuraminidase
B.       
The main surface antigens are haemolysin and neuroxidase
C.       
The main surface antigens frequently
D.       
The main core antigens change frequently, rendering existing vaccines impotent
E.        
The big drug companies avoid making a universal vaccine for financial reasons.
Option List
1.        
A + C + D + E
2.        
A + C
3.        
A + D + E
4.        
B + C
5.        
 B + D + E
Question 4.
Lead-in
When is flu’ most often a problem in the UK?
Pick the best option from the following list.
Option List
A.       
Spring
B.       
Summer
C.       
Autumn
D.       
Winter
E.        
None of the above.
Question 5.
Lead-in
How is flu spread?
Pick the best option from the following list.
Option List
A.       
via aerosol or droplets from respiratory tract of an infected person
B.       
via aerosol or droplets from respiratory tract or direct contact with respiratory secretions  of an infected person
C.       
from getting drenched in cold winter showers
D.       
from thinking lascivious thoughts
E.        
from toilet seats
Question 6.
Lead-in
What is the incubation period for flu?
Pick the best option from the following list.
Option List
A.       
1 – 3 days
B.       
1 – 7 days
C.       
5 – 10 days
D.       
up to 2 weeks
E.        
up to 3 weeks
Question 7.
Lead-in
Who decides which viruses will be used in the vaccine for seasonal flu?
Pick the best option from the following list.
Option List

  1.  
DOH

  1.  
JCVI

  1.  
the Prime Minister

  1.  
the vaccine manufacturers

  1.  
WHO
Question 8.
Lead-in
How long has flu vaccination been recommended in the UK?
Pick the best option from the following list.
Option List
A.       
since the 1950s
B.       
since the 1960s
C.       
since the 1970s
D.       
since the 1980s
E.        
since the 1990s
Question 9.
Lead-in
What is the recommendation about when the vaccine should be given?
Pick the best option from the following list.
Option List
A.       
May - July
B.       
June - August
C.       
July - September
D.       
August - October
E.        
September - November
Question 10.
Lead-in
What advice is given about vaccination in pregnancy?
Pick the best option from the following list.
Option List
A.       
flu vaccine is potentially teratogenic and should be avoided before 16 weeks
B.       
the vaccine contains an attenuated virus with no evidence of risk in pregnancy
C.       
the vaccine recommended for pregnancy has no live viral material and all pregnant women are encouraged to have the seasonal vaccine
D.       
flu vaccine contains an attenuated virus with minimal risk, but the anti-viral drug Tamiflu is given with the vaccine to eliminate any risk of harm
Question 11.
Lead-in
What is the H1N1 virus?
Pick the best option from the following list.
Option List

A.       
The avian virus which causes outbreaks of “bird flu”
B.       
The virus associated with “swine” flu, which caused a pandemic in 2009
C.       
The virus associate with MERS, currently causing deaths particularly in Saudi Arabia
D.       
The virus associated with simian flu
E.        
The virus associated with the pandemic of 1915.
Question 12.
Lead-in
What advice should be given to pregnant women about protection against the H1N1 virus?
Pick the best option from the following list.
Option List
F.        
to have vaccination against H1N1 in addition to the seasonal vaccine
G.       
to have vaccination against H1N1 in preference to the seasonal vaccine
H.       
to await evidence of epidemic H1N1 flu and then have vaccination against H1N1
I.         
to have the seasonal vaccine as it gives good protection against H1N1
J.         
not to have any flu vaccination, but to take antiviral drugs if symptoms of flu occur
Question 13.
Lead-in
Pick the best option from the following list.
Which of the following conditions have been linked to flu in pregnancy?
Conditions.
A.       
­ risk of flu complications for the mother
B.       
­ risk of low birthweight
C.       
­ risk of maternal death
D.       
­ risk of perinatal death
E.        
­ risk of  prematurity
Option List
1
A + C+ D + E
2
A + B + C+ D
3
A + C + D
4
A + C+ D + E
5
A + B + C+ D + E
Question 14.
Lead-in
What is the estimated uptake of flu vaccination by pregnant women in the UK?
Pick the best option from the following list.
Option List
A.       
20-30%
B.       
30-40%
C.       
40-50%
D.       
50-60%
E.        
> 60%
Question 15.
Lead-in
How many maternal deaths from flu were reported by MBRRACE for the years 2012 - 2013?
Pick the best option from the following list.
Option List
A.       
0
B.       
5
C.       
10
D.       
15
E.        
20
Question 16.
Lead-in
With regard to the probable explanation for the numbers of maternal deaths from ‘flu in 2012 and 2013,        which of the following statements is true?
Option List
A.       
the numbers reflected increased prevalence of ‘flu
B.       
the numbers reflected reduced prevalence of ‘flu
C.       
the numbers reflected improved uptake of ‘flu vaccine in pregnancy
D.       
the numbers reflected the introduction of Tamiflu for pregnant women with ‘flu
E.        
none of the above

60. Kallmann’s syndrome.
Lead-in.
Pick one option from the option list.
Each option can be used once, more than once or not at all.
Abbreviations.
Ks:         Kallmann’s syndrome
Scenario 1.                
Which of the following might be included in descriptions of Kallmann’s syndrome?
Option list.
A
hypogonadotrophic hypogonadism
B
hypogonadotrophic hypogonadism + anosmia
C
hypogonadotrophic hypogonadism + anosmia + colour-blindness.
D
hypogonadotrophic hypogonadism due to uterine agenesis
Scenario 2.                
Lead in.
Which, if any, of the following are features of the Kallmann phenotype?
A
absent or minimal breast development
B
aortic stenosis
C
blue eyes
D
blue hair
E
hot flushes
F
short stature
G
tall stature
H
vaginal agenesis
I
none of the above
Scenario 3.                
How common is Kallmann’s syndrome and what is the female: male ratio?
A
1 in 1,000 and F:M ratio 1:1
B
1 in 5,000 and F:M ratio 1:1
C
1 in 10,000 and F:M ratio 1:4
D
1 in 50,000 and F:M ratio 1:4
E
1 in 100,000 and F:M ratio 1:8
F
1 in 250,000 and F:M ration 1:10
Scenario 4.                
What is the most common mode of inheritance of Ks?
Option list.
A
hypogonadotrophic hypogonadism
B
hypogonadotrophic hypogonadism + anosmia
C
hypogonadotrophic hypogonadism due to uterine agenesis
D
autosomal dominant
E
autosomal recessive
F
X-linked recessive
G
new mutation of the ANOS1 gene
H
the most common mode of inheritance is not known
Scenario 5.                
How is Kallmann’s syndrome diagnosed?
A
abdominal and pelvic ultrasound scan
B
cell-free fetal DNA
C
chromosome analysis
D
CT scan of hypothalamus / pituitary
E
MR scan of hypothalamus / pituitary
F
none of the above.
Scenario 6.                
How is Kallmann’s syndrome treated initially?
Which of the following statements are true?
Option list.
A
GnRH analogue depot
B
pulsatile GnRH therapy
C
combined oral contraceptive
D
counselling & education re gender re-assignment
E
depot progestogen
F
none of the above
Scenario 7.                
A woman was diagnosed with Kallmann’s syndrome at 16 and had successful initial treatment. She is now 25, married and wishes to have a pregnancy. She has had pre-pregnancy assessment and counselling. Which of the following can be considered?
A
GnRH analogue depot
B
induction of ovulation with clomiphene
C
gonadotrophin therapy
D
pulsatile GnRH therapy
E
none of the above





No comments:

Post a Comment